Title |
ERK2, but Not ERK1, Mediates Acquired and “De novo” Resistance to Imatinib Mesylate: Implication for CML Therapy
|
---|---|
Published in |
PLOS ONE, July 2009
|
DOI | 10.1371/journal.pone.0006124 |
Pubmed ID | |
Authors |
Clara I. Aceves-Luquero, Anupriya Agarwal, Juan L. Callejas-Valera, Laura Arias-González, Azucena Esparís-Ogando, Luis del Peso Ovalle, Itxaso Bellón-Echeverria, Miguel A. de la Cruz-Morcillo, Eva M. Galán Moya, Inmaculada Moreno Gimeno, Juan C. Gómez, Michael W. Deininger, Atanasio Pandiella, Ricardo Sánchez Prieto |
Mendeley readers
The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Poland | 1 | 3% |
Czechia | 1 | 3% |
Canada | 1 | 3% |
Unknown | 37 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 12 | 30% |
Student > Ph. D. Student | 7 | 18% |
Professor > Associate Professor | 5 | 13% |
Student > Master | 3 | 8% |
Student > Bachelor | 2 | 5% |
Other | 5 | 13% |
Unknown | 6 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 10 | 25% |
Agricultural and Biological Sciences | 10 | 25% |
Medicine and Dentistry | 7 | 18% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
Mathematics | 1 | 3% |
Other | 5 | 13% |
Unknown | 5 | 13% |